These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23481900)
1. Does anti-JCV therapy improve the prognosis of AIDS-related PML? Mikita K; Maeda T; Fujikura Y; Kozaki Y; Hara Y; Kanoh S; Kishida S; Saijo M; Nakamichi K; Kawana A Clin Neurol Neurosurg; 2013 Sep; 115(9):1853-4. PubMed ID: 23481900 [No Abstract] [Full Text] [Related]
2. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422 [TBL] [Abstract][Full Text] [Related]
3. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P J Neurovirol; 2013 Aug; 19(4):351-8. PubMed ID: 23733308 [TBL] [Abstract][Full Text] [Related]
4. Immunosuppression increases JC polyomavirus large T antigen DNA load in the brains of patients without progressive multifocal leukoencephalopathy. Bayliss J; Karasoulos T; McLean CA J Infect Dis; 2013 Jan; 207(1):133-6. PubMed ID: 23112281 [TBL] [Abstract][Full Text] [Related]
5. Management of infections by the human polyomavirus JC: past, present and future. Hou J; Major E Expert Rev Anti Infect Ther; 2005 Aug; 3(4):629-40. PubMed ID: 16107201 [TBL] [Abstract][Full Text] [Related]
7. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217 [TBL] [Abstract][Full Text] [Related]
8. A case of progressive multifocal leukoencephalopathy in a patient with sarcoidosis. Pallin M; O'Sullivan C; Dodd JD; McCreery K; Brett F; Farrell M; O'Brien D; Hall WW; Tubridy NJ; Keane MP QJM; 2012 Oct; 105(10):1011-6. PubMed ID: 21893584 [No Abstract] [Full Text] [Related]
9. Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient. Adachi E; Koibuchi T; Imai K; Kikuchi T; Koga M; Nakamura H; Miura T; Iwamoto A; Fujii T Int J STD AIDS; 2012 Aug; 23(8):603-5. PubMed ID: 22930304 [TBL] [Abstract][Full Text] [Related]
10. Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report. Cifci B; Yildiz Y; Altin E; Habibi H; Kocer B; Dizbay M J Neurovirol; 2023 Feb; 29(1):111-115. PubMed ID: 36795262 [TBL] [Abstract][Full Text] [Related]
11. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection. Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477 [TBL] [Abstract][Full Text] [Related]
13. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV. Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A Viruses; 2022 May; 14(5):. PubMed ID: 35632711 [TBL] [Abstract][Full Text] [Related]
14. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients]. Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609 [TBL] [Abstract][Full Text] [Related]
15. Polyomavirus JCV excretion and genotype analysis in HIV-infected patients receiving highly active antiretroviral therapy. Lednicky JA; Vilchez RA; Keitel WA; Visnegarwala F; White ZS; Kozinetz CA; Lewis DE; Butel JS AIDS; 2003 Apr; 17(6):801-7. PubMed ID: 12660526 [TBL] [Abstract][Full Text] [Related]
16. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine. Kurmann R; Weisstanner C; Kardas P; Hirsch HH; Wiest R; Lämmle B; Furrer H; Du Pasquier R; Bassetti CL; Sturzenegger M; Krestel H J Neurovirol; 2015 Dec; 21(6):694-701. PubMed ID: 25916731 [TBL] [Abstract][Full Text] [Related]
17. Macrophage chemoattractant protein-1 levels in cerebrospinal fluid correlate with containment of JC virus and prognosis of acquired immunodeficiency syndrome--associated progressive multifocal leukoencephalopathy. Marzocchetti A; Cingolani A; Giambenedetto SD; Ammassari A; Giancola ML; Cauda R; Antinori A; Luca AD J Neurovirol; 2005 Apr; 11(2):219-24. PubMed ID: 16036800 [TBL] [Abstract][Full Text] [Related]
18. Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? Mornese Pinna S; Scarvaglieri E; Milia MG; Imperiale D; Ghisetti V; Audagnotto S; Prochet A; Lipani F; Bonora S; Di Perri G; Calcagno A J Neurovirol; 2017 Oct; 23(5):763-767. PubMed ID: 28681343 [TBL] [Abstract][Full Text] [Related]
19. [A case of cerebellar brainstem form of progressive multifocal leukoencephalopathy associated with idiopathic CD4+ lymphocytopenia]. Izaki S; Tanaka S; Tajima T; Nakamichi K; Saijo M; Nomura K Rinsho Shinkeigaku; 2015; 55(5):345-8. PubMed ID: 26028198 [TBL] [Abstract][Full Text] [Related]
20. A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus. Ramadhani P; Bramantono B; Sedana MP Acta Med Indones; 2018 Apr; 50(2):151-158. PubMed ID: 29950535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]